Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
The PrEP Access Act amends Medicare Part B to make pharmacist-provided HIV prevention services (PrEP, PEP, related evaluation, counseling, medication administration, and diagnostic tests) covered when pharmacists are authorized under state law.
It sets a payment rule (beneficiary Medicare payment equal to 80% of the lesser of actual charge or 85% of the physician-based amount), prohibits balance billing for pharmacist services, excludes non‑reasonable services, and applies to services furnished on or after January 1, 2027.
Technocratic, limited-cost expansion with plausible bipartisan support, but faces fiscal scrutiny and Senate procedural hurdles.
Relative to its intended legislative type, this bill clearly and directly amends Medicare statute to authorize and define coverage for pharmacist-provided HIV prevention services, specifies a concrete payment rule, updates balance-billing and noncoverage provisions, and sets an effective date.
Left emphasizes access, equity, and ending balance billing protections.
Left emphasizes access, equity, and ending balance billing protections.
Likely broadly supportive because the bill expands access to HIV prevention services and uses pharmacists to lower barriers.
Will welcome Medicare coverage and the balance-billing prohibition while wanting stronger guarantees on equitable access and adequate reimbursement.
Generally favorable but pragmatic: supports improving access while wanting fiscal clarity and implementation details.
Sees value in pharmacists expanding preventive care but will seek CBO cost estimates and monitoring of utilization and quality.
Skeptical of expanding federal coverage to non-physician providers and concerned about added Medicare spending.
May accept limited pharmacist roles under state law, but will question reimbursement incentives and scope expansion implications.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic, limited-cost expansion with plausible bipartisan support, but faces fiscal scrutiny and Senate procedural hurdles.
The bill has not accumulated any surfaced votes yet.
Left emphasizes access, equity, and ending balance billing protections.
Technocratic, limited-cost expansion with plausible bipartisan support, but faces fiscal scrutiny and Senate procedural hurdles.
Relative to its intended legislative type, this bill clearly and directly amends Medicare statute to authorize and define coverage for pharmacist-provided HIV prevention services, specifies a concrete payment rule, upda…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.